NovoCure LimitedNVCRNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank42
Studio
Year-over-Year Change

Cash generated from core business operations

Percentile
P42
Within normal range
vs 5Y Ago
-0.5x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$-49.03M-85.9%
2024$-26.37M+64.0%
2023$-73.34M-338.2%
2022$30.79M-62.8%
2021$82.76M-16.5%
2020$99.15M+272.5%
2019$26.62M+1527.3%
2018$-1.86M+94.4%
2017$-33.13M+69.2%
2016$-107.59M-